New Search

If you are not happy with the results below please do another search

2034 search results for:

1931

New toolkit to assess musculoskeletal health in older people

A new way to assess the impact of normal ageing on bones, joints and muscles has been proposed that could provide a benchmark for how well older people are able to keep moving. The composition of the body changes as we get older, as muscle strength and bone density decline. But the challenge to date […]

1932

Tracing the footprints of a tumour: genomic “scars” allow cancer profiling

DNA mutations driving cancer development are caused by different mechanisms, each of them leaving behind specific patterns, or “scars” in the genome. Using CRISPR-Cas9 technology, researchers at CeMM and the Wellcome Trust Sanger Institute at Cambridge, UK were able to show for the first time in cell culture that specific genetic alterations indeed lead to […]

1933

bioLOGICAL – Safety when it matters. Third edition of the Greiner Bio-One customer magazine.

The third edition of the Greiner Bio-One customer magazine bioLOGICAL is now available on the company’s website. The issue presents the Helsingborg-based company Vigmed and its products. The Swedish company was taken over by Greiner Bio-One in 2017. Helpful information about arterial and venous catheters as well as an informative interview about the development and […]

1934

Colorectal cancer screening campaigns can save more than 130,000 lives annually

Digestive Cancers Europe has launched a campaign to promote colorectal cancer screening at the occasion of the start of European Colon Cancer Awareness Month (ECCAM). The event took place at the European Parliament and was hosted by MEP Lieve Wierinck (ALDE). The Basque region, the Netherlands and Slovenia show the way… Building on the successful […]

1935

Special antibodies could lead to HIV vaccine

A small number of people who are infected with HIV-1 produce very special antibodies. These antibodies do not just fight one virus strain, but neutralize almost all known virus strains. Research into developing an HIV vaccine focuses on discovering the factors responsible for the production of such antibodies.A Swiss research team led by the University […]

1936

Volunteer laboratory network launched in UK to expand Covid-19 testing

The UK-based Covid-19 Volunteer Testing Network launched April 9 to provide essential additional testing capacity to front-line workers. The project, started by Mike Fischer CBE, helps small laboratories convert to run critical antigen testing and identify Covid-19 cases among local healthcare workers – at no cost to Government. The UK has thousands of small laboratories […]

1937

Using whole-genome sequencing for early identification and containment of AMR pathogens

A recently published study examines the evolutionary and epidemiologic history of an epidemic strain of extensively drug-resistant tuberculosis (XDR-TB) – called LAM4/KZN – in KwaZulu-Natal, South Africa. This strain was first reported in a 2005 outbreak in Tugela Ferry, KwaZulu-Natal, where it was associated with 90 % mortality among predominantly HIV infected individuals, and has […]

1938

Randox RX series gains NGSP certification for direct HbA1c

Randox Laboratories recently announced its achievement in being awarded the Manufacturer Certification by the National Glycohemoglobin Standardization Program (NGSP) for direct HbA1c testing on three of its clinical chemistry analysers: the RX modena, RX imola and RX daytona+. NGSP is recommended for laboratories conducting diabetes-related clinical trials and is only granted on the basis of […]

1939

Byondis investigational breast cancer drug selected for trial

Byondis B.V. (formerly Synthon Biopharmaceuticals) announced that Quantum Leap Healthcare Collaborative (Quantum Leap) selected the company’s investigational antibody-drug conjugate (ADC) SYD985 ([vic-]trastuzumab duocarmazine) for a new investigational treatment arm in its ongoing I-SPY 2 TRIAL for neoadjuvant treatment of locally advanced breast cancer. This treatment arm will focus on treatment for HER2-low early-stage breast cancer. […]

1940

Roche to launched COVID-19 antibody test in early May

Roche will develop its Elecsys Anti-SARS-CoV-2 serology test to detect antibodies in people who have been exposed to SARS-CoV-2 and launch it in early May in countries accepting the CE mark. The company says it is actively working with the FDA for an Emergency Use Authorisation. The Elecsys Anti-SARS-CoV-2 immunoassay is an in vitro test, […]